CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 14, 2026

Total Value ($000): $4,024 (100.0% shares, 0.0% debt)

Holdings (7)

New Positions (1)

ALXO ALX ONCOLOGY HLDGS INC 1.0%

Value ($000) $42 Shares 20,946 Est. Cost $1.77 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALXO	ALX ONCOLOGY HLDGS INC	20,946	$42	1.0%	$1.77	0.0%	COM	00166B105

Increased Positions (2)

GLD SPDR GOLD TR 81.5%

Value ($000) $3,280 (+18.8%) Shares 7,623 (+9.5%) Est. Cost $321.04 Unrealized —

BRK/B BERKSHIRE HATHAWAY INC DEL 8.7%

Value ($000) $348 (-2.4%) Shares 727 (+2.4%) Est. Cost $411.72 Unrealized +19.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
GLD	SPDR GOLD TR	7,623 (+9.5%)	$3,280 (+18.8%)	81.5%	$321.04	—	GOLD SHS	78463V107
BRK/B	BERKSHIRE HATHAWAY INC DEL	727 (+2.4%)	$348 (-2.4%)	8.7%	$411.72	+19.9%	CL B NEW	084670702

Exited Positions (5)

SYRE SPYRE THERAPEUTICS INC 7.3%

Value ($000) $292 Shares 8,919 Est. Cost $26.13 Unrealized +32.2%

— MIND MEDICINE MINDMED INC 5.2%

Value ($000) $210 Shares 15,688 Est. Cost $8.91 Unrealized —

CMPX COMPASS THERAPEUTICS INC 3.9%

Value ($000) $158 Shares 29,495 Est. Cost $3.22 Unrealized +86.5%

SABS SAB BIOTHERAPEUTICS INC 1.0%

Value ($000) $39 Shares 10,527 Est. Cost $2.26 Unrealized +77.0%

CNTX CONTEXT THERAPEUTICS INC 0.7%

Value ($000) $27 Shares 18,403 Est. Cost $1.72 Unrealized +18.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
SYRE	SPYRE THERAPEUTICS INC	8,919	$292	7.3%	$26.13	+32.2%	—	00773J202
—	MIND MEDICINE MINDMED INC	15,688	$210	5.2%	$8.91	—	—	60255C885
CMPX	COMPASS THERAPEUTICS INC	29,495	$158	3.9%	$3.22	+86.5%	—	20454B104
SABS	SAB BIOTHERAPEUTICS INC	10,527	$39	1.0%	$2.26	+77.0%	—	78397T202
CNTX	CONTEXT THERAPEUTICS INC	18,403	$27	0.7%	$1.72	+18.9%	—	21077P108

Unchanged Positions (4)

LXEO LEXEO THERAPEUTICS INC 2.0%

Value ($000) $80 Shares 13,943 Est. Cost $13.31 Unrealized -43.4%

KYTX KYVERNA THERAPEUTICS INC 4.0%

Value ($000) $162 Shares 18,773 Est. Cost $23.94 Unrealized -65.3%

IKT INHIBIKASE THERAPEUTICS INC 1.2%

Value ($000) $48 Shares 28,453 Est. Cost $2.11 Unrealized -17.9%

XFOR X4 PHARMACEUTICALS INC 1.6%

Value ($000) $64 Shares 15,557 Est. Cost $3.63 Unrealized +0.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LXEO	LEXEO THERAPEUTICS INC	13,943	$80	2.0%	$13.31	-43.4%	COM	52886X107
KYTX	KYVERNA THERAPEUTICS INC	18,773	$162	4.0%	$23.94	-65.3%	COM	501976104
IKT	INHIBIKASE THERAPEUTICS INC	28,453	$48	1.2%	$2.11	-17.9%	COM NEW	45719W205
XFOR	X4 PHARMACEUTICALS INC	15,557	$64	1.6%	$3.63	+0.1%	COM NEW	98420X202